Catalyst Pharmaceuticals, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 31.49 USD (Jul 15, 2026, 4:00 PM EDT) · Market cap 3.85B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Details
| Name | Catalyst Pharmaceuticals, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 182 |
| Founded | 2002 |
| Ipo Date | 2006-11-08 |
| Ceo | Richard John Daly |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US14888U1016 |
| Cusip | 14888U101 |
| Cik | 0001369568 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Richard John Daly M.B.A. | President, Chief Executive Officer and Director |
| Patrick J. McEnany | Co-Founder and Non-Executive Chairman |
| Michael W. Kalb CPA | Executive Vice President, Treasurer and Chief Financial Officer |
| Dr. Steven R. Miller Ph.D. | Executive Vice President, Chief Operating Officer and Chief Scientific Officer |
| Jeffrey Del Carmen | Executive Vice President and Chief Commercial Officer |
| Dr. William T. Andrews FACP, M.D. | Chief Medical Officer |
| Mary Coleman | Vice President and Head of Investor Relations |
| Brian Elsbernd J.D. | Chief Compliance Officer and Chief Legal Officer |
| Gregg Russo | Chief Human Resources Officer |
| Dr. Preethi Sundaram Ph.D. | Chief Strategy Officer |
Contact
| Address | 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, United States |
| Phone | 305 420 3200 |
| Website | https://catalystpharma.com |